Invesco Dorsey Wright Healthcare Momentum ETF Rating → 4 coins to be the “Next Bitcoin” (From True Market Insiders) (Ad) Free PTH Stock Alerts $39.88 +0.70 (+1.79%) (As of 04/26/2024 ET) Add Compare Share Share RatingsStock AnalysisChartHoldingsOptions ChainOwnershipRatingsSocial MediaStock AnalysisChartHoldingsOptions ChainOwnershipRatingsSocial Media Invesco Dorsey Wright Healthcare Momentum ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PTH Aggregate RatingModerate Buy2.76Holdings in PTH have an aggregate rating of Moderate Buy based on 400 analyst ratings issued in the past year covering 49 companies (93.3% of the portfolio).PTH Aggregate Price Target$49.2423.46% UpsideHigh Prediction$64.82Average Prediction$49.24Low Prediction$32.59Holdings in PTH have an aggregate price target of $49.24 and a range of $32.59 to $64.82 covering 49 companies (93.3% of the portfolio).PTH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy19 Buy rating(s)Moderate Buy24 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco Dorsey Wright Healthcare Momentum ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 49 PTH Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.03%LLYEli Lilly and Company$733.51+1.2%5 of 5 stars2.84$728.05 -0.7%19Upcoming Earnings4.68%IDXXIDEXX Laboratories$499.30+2.1%4 of 5 stars2.67$591.50 18.5%9Upcoming EarningsPositive News4.57%MEDPMedpace$395.93+1.6%5 of 5 stars2.80$443.00 11.9%5Earnings ReportAnalyst UpgradeAnalyst RevisionNews Coverage4.47%ALPNAlpine Immune Sciences$64.56-0.1%2 of 5 stars2.27$50.33 -22.0%11Short Interest ↓3.14%THCTenet Healthcare$96.13-1.4%5 of 5 stars3.00$100.38 4.4%16Upcoming EarningsGap Down2.90%CORCencora$240.88+0.5%4 of 5 stars2.63$218.22 -9.4%8Upcoming Earnings2.86%NTRANatera$91.66+0.4%2 of 5 stars3.00$86.40 -5.7%14Analyst DowngradeInsider Selling2.70%REGNRegeneron Pharmaceuticals$883.20-0.8%5 of 5 stars2.70$977.77 10.7%20Upcoming EarningsAnalyst ReportAnalyst RevisionNews Coverage2.68%MOHMolina Healthcare$342.23-2.9%5 of 5 stars2.33$396.09 15.7%9Earnings ReportAnalyst ReportShort Interest ↓News Coverage2.67%VERAVera Therapeutics$39.65+2.5%1 of 5 stars3.00$32.29 -18.6%82.63%ABBVAbbVie$159.62-4.6%5 of 5 stars2.77$177.43 11.2%13Earnings ReportNews CoverageHigh Trading Volume2.56%DVADaVita$133.51+0.6%4 of 5 stars2.33$118.50 -11.2%3Upcoming EarningsAnalyst UpgradeShort Interest ↓News Coverage2.46%RNAAvidity Biosciences$24.36+2.2%1 of 5 stars3.00$36.33 49.2%62.32%ARQTArcutis Biotherapeutics$8.47-1.4%2 of 5 stars2.75$26.56 213.5%8Options VolumeNews Coverage2.23%IDYAIDEAYA Biosciences$39.94+3.4%3 of 5 stars3.00$46.60 16.7%122.07%IBRXImmunityBio$7.35+43.8%0 of 5 stars2.00$5.00 -32.0%1Options VolumeNews CoverageHigh Trading Volume1.99%MDGLMadrigal Pharmaceuticals$193.33-0.5%5 of 5 stars2.73$356.73 84.5%111.95%BHVNBiohaven$38.97+1.1%4 of 5 stars3.00$52.13 33.8%8Analyst ReportInsider BuyingAnalyst RevisionNews Coverage1.91%KRYSKrystal Biotech$156.88+0.8%4 of 5 stars3.00$171.00 9.0%91.76%LQDALiquidia$12.53+1.3%2 of 5 stars2.60$21.00 67.6%5Upcoming Earnings1.75%ENSGThe Ensign Group$117.250.0%4 of 5 stars2.80$123.60 5.4%5Upcoming EarningsAnalyst ReportNews Coverage1.68%RDNTRadNet$48.40-0.9%4 of 5 stars2.67$53.67 10.9%31.67%MRUSMerus$45.04+0.2%2 of 5 stars3.00$56.33 25.1%11Upcoming EarningsAnalyst RevisionNews Coverage1.64%DYNDyne Therapeutics$24.73+4.4%4 of 5 stars3.14$37.43 51.3%7Short Interest ↑News Coverage1.55%GKOSGlaukos$99.48-0.6%4 of 5 stars2.78$99.80 0.3%9Upcoming EarningsShort Interest ↓1.53%PCVXVaxcyte$60.72+1.1%2 of 5 stars3.00$78.50 29.3%4Insider SellingNews Coverage1.51%SYRESpyre Therapeutics$33.56+3.4%1 of 5 stars3.00$39.20 16.8%71.47%APGEApogee Therapeutics$47.13+2.8%1 of 5 stars3.00$71.83 52.4%71.43%VCELVericel$46.05+1.3%0 of 5 stars3.00$46.40 0.8%6News Coverage1.42%CRNXCrinetics Pharmaceuticals$42.12-0.4%4 of 5 stars2.91$54.00 28.2%11Upcoming EarningsShort Interest ↑1.41%ITCIIntra-Cellular Therapies$73.26+1.6%4 of 5 stars2.90$90.17 23.1%10Upcoming EarningsAnalyst ReportAnalyst Revision1.37%NUVLNuvalent$66.86+1.2%3 of 5 stars2.90$90.78 35.8%10Insider Selling1.29%BPMCBlueprint Medicines$93.00+2.5%1 of 5 stars2.50$91.57 -1.5%14Upcoming EarningsAnalyst ReportNews CoverageGap Up1.29%KURAKura Oncology$19.65+3.4%4 of 5 stars2.88$28.28 43.9%8Upcoming Earnings1.20%SWTXSpringWorks Therapeutics$45.53+3.0%3 of 5 stars3.00$68.00 49.4%6Upcoming EarningsNews Coverage1.13%LFMDLifeMD$11.95+10.4%1 of 5 stars3.00$10.40 -13.0%5Analyst Report1.13%ADMAADMA Biologics$6.55+1.7%3 of 5 stars3.25$7.88 20.2%4Short Interest ↑1.09%HIMSHims & Hers Health$12.50+1.9%3 of 5 stars2.62$14.85 18.8%13Short Interest ↑News Coverage1.09%FATEFate Therapeutics$3.80-1.8%4 of 5 stars2.08$6.73 77.0%12Upcoming EarningsAnalyst ReportShort Interest ↑News Coverage1.03%KROSKeros Therapeutics$57.86+6.8%2 of 5 stars3.00$86.00 48.6%7Upcoming Earnings1.03%OCULOcular Therapeutix$4.75+12.8%4 of 5 stars3.00$17.60 270.9%5Short Interest ↑1.00%PRAXPraxis Precision Medicines$54.80+3.6%2 of 5 stars2.75$103.00 88.0%4Analyst ReportShort Interest ↑News Coverage0.98%UFPTUFP Technologies$213.25+1.7%2 of 5 stars2.50$238.50 11.8%2Positive News0.97%BKDBrookdale Senior Living$6.96+1.5%3 of 5 stars2.50$7.50 7.8%2Positive News0.88%SILKSilk Road Medical$17.80+0.8%3 of 5 stars2.18$22.18 24.6%11Upcoming Earnings0.85%ANIPANI Pharmaceuticals$65.36+0.6%4 of 5 stars3.00$80.00 22.4%4Analyst ReportShort Interest ↑0.81%COLLCollegium Pharmaceutical$36.42+1.6%2 of 5 stars2.60$39.00 7.1%5Analyst UpgradeNews Coverage0.80%LMATLeMaitre Vascular$65.46+3.9%3 of 5 stars2.71$69.33 5.9%7Upcoming EarningsAnalyst UpgradeNews CoverageGap Up0.73%FULCFulcrum Therapeutics$7.14+0.1%2 of 5 stars2.83$13.17 84.4%6Short Interest ↑Negative News This page (NASDAQ:PTH) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressJeff Bezos Just Humiliated Elon MuskInvestorPlaceThe World's First "$20 Trillion Drug?"Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Dorsey Wright Healthcare Momentum ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
